Results 191 to 200 of about 12,753 (211)

Revisiting ICD Use in Chagas Cardiomyopathy: Current Evidence and Future Directions. [PDF]

Arq Bras Cardiol
Carmo A, Ribeiro ALP.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection

Clinical Microbiology Reviews, 2022
Alba Abras, Montserrat Gállego
exaly  

New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial

Lancet Infectious Diseases, The, 2021
Igor C Almeida, Cristina Alonso-Vega, Isabela Ribeiro   +2 more
exaly  

Anti-trypanosomatid drug discovery: progress and challenges

Nature Reviews Microbiology, 2022
Manu De Rycker, David A Horn, Kevin D Read   +2 more
exaly  

Pathology and Pathogenesis of Chagas Heart Disease

Annual Review of Pathology: Mechanisms of Disease, 2019
Nisha J Garg, David M Engman
exaly  

Chagas Disease in the United States: a Public Health Approach

Clinical Microbiology Reviews, 2019
Louisa A Messenger, Jeffrey D Whitman
exaly  

Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association

Circulation, 2018
Walderez Dutra, Joaquim Gascon, Carlos A Morillo   +2 more
exaly  

Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need

Nature Reviews Microbiology, 2017
Mark C Field, David A Horn, Alan H Fairlamb   +2 more
exaly  

Global economic burden of Chagas disease: a computational simulation model

Lancet Infectious Diseases, The, 2013
Bruce Y Lee, Maria Elena Bottazzi, Peter J Hotez   +2 more
exaly  

Pathogenesis of Chronic Chagas Heart Disease

Circulation, 2007
Jose Antônio Marin-Neto
exaly